Universal Biosensors Inc (UBI) Financial Statements (2025 and earlier)

Company Profile

Business Address 1 CORPORATE AVENUE
VICTORIA, 3178
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,24025,97815,31823,56230,23011,798
Cash and cash equivalents10,24025,97815,31823,56230,23011,798
Restricted cash and investments355271,9692,1752,05516
Receivables2,1269744767311750,210
Inventory, net of allowances, customer advances and progress billings4,3783,1422,1441,8801,078744
Inventory4,3783,1422,1441,8801,078744
Prepaid expense1,200490399108136158
Other current assets2508254,5443,5993,4571,105
Other undisclosed current assets3,7744,736    
Total current assets:22,00336,67224,85031,39637,07364,031
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization4958   
Operating lease, right-of-use asset2,6634,422   
Property, plant and equipment4,8484,5834,1004,3554,7505,626
Intangible assets, net (including goodwill)  11,01512,65114,28715,928 
Intangible assets, net (excluding goodwill)  11,01512,65114,28715,928 
Restricted cash and investments3203208122,3194,908320
Other noncurrent assets908938   
Other undisclosed noncurrent assets  (11,015)2,0504,025  
Total noncurrent assets:7,9709,47319,65224,98625,5865,946
TOTAL ASSETS:29,97346,14544,50256,38262,65969,978
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,2986,1563,9082,2022,4137,942
Taxes payable   4,353
Employee-related liabilities6706037821,197
Accounts payable1,241268437448615695
Accrued liabilities2,0575,8882,8011,1521,0151,697
Deferred revenue3630381,6282,682
Debt9207565   
Business combination, contingent consideration, liability  2,2142,0671,5002,141 
Other liabilities  3,0242,8232,6602,9242,903
Other undisclosed current liabilities1,6951,587500972 2,357
Total current liabilities:5,94913,0869,4028,96310,16113,201
Noncurrent Liabilities
Long-term debt and lease obligation46561,6913,635  
Long-term debt, excluding current maturities    41  
Finance lease, liability4656   
Liabilities, other than long-term debt4,3946,8645,7725,7867,0732,600
Deferred revenue     1,422
Asset retirement obligations1,2142,9212,7212,7352,6002,600
Deferred income tax liabilities   3,0513,0513,051
Operating lease, liability3,1793,9441,6913,595 
Other undisclosed noncurrent liabilities76482921323,503
Total noncurrent liabilities:4,5166,9687,4929,4427,1056,103
Total liabilities:10,46520,05416,89418,40417,26519,304
Equity
Equity, attributable to parent, including:19,50826,09127,60837,97745,39450,674
Common stock212118181818
Additional paid in capital119,239119,04193,73893,57093,39793,815
Accumulated other comprehensive loss(332)(292)(323)(293)(342)(326)
Accumulated deficit(92,679)(65,824)(55,317)(47,679)(42,833)(80,397)
Other undisclosed equity, attributable to parent(6,742)(26,855)(10,507)(7,638)(4,846)37,564
Total equity:19,50826,09127,60837,97745,39450,674
TOTAL LIABILITIES AND EQUITY:29,97346,14544,50256,38262,65969,978

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues11,0399,3585,7783,2036,89769,948
Other income5,74021123  
Cost of revenue
(Cost of Goods and Services Sold)
(2,348)(2,386)(3,672)(2,580)(3,572)(2,511)
Other undisclosed gross profit(4,406)(4,833)   (491)
Gross profit:4,2852,1392,1066233,32666,945
Operating expenses(20,965)(37,033)(17,144)(13,181)(13,725)(20,523)
Operating income (loss):(16,680)(34,894)(15,038)(12,558)(10,400)46,423
Nonoperating income (expense)9,9394,9884,5314,9204,236(4,506)
Investment income, nonoperating73438250294826491
Other nonoperating income5,9161824312,12357 
Interest and debt expense    (155) (2,991)
Income (loss) from continuing operations before equity method investments, income taxes:(6,742)(29,905)(10,507)(7,793)(6,164)38,926
Other undisclosed income from continuing operations before income taxes    155 2,991
Income (loss) from continuing operations before income taxes:(6,742)(29,905)(10,507)(7,638)(6,164)41,917
Income tax expense (benefit)  3,051  1,317(4,353)
Income (loss) from continuing operations:(6,742)(26,855)(10,507)(7,638)(4,846)37,564
Income (loss) before gain (loss) on sale of properties:(10,507)(7,638)(4,846)37,564
Net income (loss) available to common stockholders, diluted:(6,742)(26,855)(10,507)(7,638)(4,846)37,564

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(6,742)(26,855)(10,507)(7,638)(4,846)37,564
Other comprehensive income (loss)(40)32(30)49(16)(24)
Comprehensive income (loss), net of tax, attributable to parent:(6,782)(26,823)(10,537)(7,589)(4,862)37,540

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: